Y-Intercept (HK)’s Infinity Pharmaceuticals, Inc. INFI Stock Holding History

Y-Intercept (HK)’s Portfolio INFI Stock Details INFI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-22,849	Closed	-$4.81K	–	1779
2023 Q2	$4.81K	Buy	+22,849	New	+$3.97K	﹤0.01%	1217
2022 Q3	–	Sell	-41,396	Closed	-$26K	–	1358
2022 Q2	$26K	Buy	+41,396	New	+$31.8K	﹤0.01%	779

Other funds holding INFI

XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

SPIA

Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return

Y-Intercept (HK)'s INFI Position: Q3 2023 in Review

Y-Intercept (HK) sold out of Infinity Pharmaceuticals, Inc. (INFI) in Q3 2023, closing a stake of 22,849 shares — an estimated $4.81K sold.

Y-Intercept (HK) first reported a position in INFI in Q2 2022 and held it in 2 quarters. The position peaked at $26K in Q2 2022. 3 funds tracked by Wall St. Rank hold INFI as of Q3 2023.

Y-Intercept (HK) reported no remaining Infinity Pharmaceuticals, Inc. position as of Q3 2023 after selling out during the quarter.
Y-Intercept (HK) sold 22,849 Infinity Pharmaceuticals, Inc. shares in Q3 2023, an estimated $4.81K.
Y-Intercept (HK) first reported a position in Infinity Pharmaceuticals, Inc. in Q2 2022 and held it in 2 quarters.
Y-Intercept (HK)'s Infinity Pharmaceuticals, Inc. position peaked at $26K in Q2 2022.
3 funds tracked by Wall St. Rank held Infinity Pharmaceuticals, Inc. as of Q3 2023.

Based on Y-Intercept (HK)'s 13F filing for Q3 2023, filed 14 Nov 2023.